0
0
8/2/23 at 4:20pm
Organization
European Pharmaceutical Review
30 words
0
Comments
The new COVID-19 vaccine authorised by the MHRA contains an adjuvant and is indicated for patients over 16 years old.
You are the first to view
https://www.europeanpharmaceuticalreview.com/news/185371/mhra-authorises-new-covid-19-vaccine/
Create an account
or login to join the discussion